Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Reports Strong 2022 Interim Results 2022-08-17 21:32
WuXi Biologics Again Selected as Constituent of FTSE4Good Index Series 2022-08-17 10:12
WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapore 2022-07-19 18:03
WuXi Vaccines Received First GMP Certificate of QC Potency Lab from Ireland Health Products Regulatory Authority 2022-07-12 16:00
WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates 2022-07-08 09:27
WuXi Biologics Extends Capabilities to Include Development and cGMP Manufacturing for Microbial-Derived Products 2022-07-05 08:30
WuXi Biologics Launches First Commercial Drug Product Facility for Pre-Filled Syringes 2022-06-06 08:30
WuXi Biologics' 2021 ESG Report Reveals Company's Strong Commitment to Overall Sustainability 2022-04-28 08:30
WuXi Biologics Receives Bioprocessing Excellence Award from IMAPAC 2022-04-15 09:03
WuXi Biologics Achieved Record Growth and Profitability in 2021 2022-03-23 00:38
WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics 2022-03-14 20:30
WuXi Biologics Wins CMO Leadership Awards in All Six Core Categories for Fifth Consecutive Year 2022-03-02 10:07
WuXi Biologics Statement 2022-02-08 11:08
WuXi Biologics Completes GMP Inspection by South Korea's Ministry of Food and Drug Safety for Drug Substance Facility 2022-01-18 10:50
WuXi Biologics Launches a New GMP Commercial Drug Product Facility 2021-11-01 10:19
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility 2021-10-28 08:30
WuXi Biologics Received First Manufacturing License from Japan and Completed 12 Global Regulatory Inspections in 2021 Year to Date 2021-09-01 14:12
WuXi Biologics Reports Strong 2021 Interim Results 2021-08-23 20:59
WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate 2021-08-02 20:13
WuXi Biologics Received Commercial Manufacturing License from German Health Authorities for its German Drug Product Facility 2021-07-26 18:00
1 2 3 4 5 9